Why the study?
Is antithrombotic therapy with warfarin, aspirin and clopidogrel the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions?
Is antithrombotic therapy with warfarin, aspirin and clopidogrel the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions?
Answers are grounded in this paper and cite their sources.
This article argues in favor of triple antithrombotic therapy (warfarin, aspirin, and clopidogrel) for anticoagulated patients undergoing PCI or presenting with ACS.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Halperin et al. (2008) conducted an editorial in Acute coronary syndrome and/or percutaneous coronary interventions. Warfarin, aspirin and clopidogrel was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: